Primary infection of human immunodeficiency virus type 1 (HIV-1) is occasionally associated with commoncold-like symptoms, and rarely with a self-limited illness resembling infectious mononucleosis. Wereport a 32-year-old manwho presented with infectious mononucleosis-like blood picture on admission. Five days after admission he developed hepatic encephalopathy, which was ameliorated by administration of bolus corticosteroid. Based on the results of serologic studies, we diagnosed that he had primary HIV-1 infection. To our knowledge, this is the first published report of hepatic encephalopathy as a clinical manifestation of primary HIV-1 infection.
Introduction
Primary human immunodeficiency virus type 1 (HIV-1) infection is occasionally associated with common cold-like symptoms, and rarely with a self-limited illness that resembles infectious mononucleosis caused by Epstein-Barr (EB) virus or cytomegalovirus. The latter illness is of sudden onset and its commonsymptoms include fever, sore throat, headache, myalgia, malaise, skin rash, and lymphadenopathy (1) (2) (3) . Other clinical manifestations of primary HIV-1 infection, such as lymphocytic alveolitis, hepatitis and neurologic disorders such as meningitis, encephalopathy, Guillain-Barre syndrome, and myelopathy, have been reported (3) (4) (5) (6) (7) (8) (9) . To our knowledge, however, there has been no report of hepatic encephalopathy caused by primary HIV-1 infection. In this paper, we report a patient
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who developed hepatic encephalopathy during primary HIV-1 infection.
Case Report
A 32-year-old Japanese man visited our hospital on November 30, 2000, because of fever over 38°C, that started on November 24. He was treated with levofloxacin under a tentative diagnosis of upper respiratory tract infection. However, the fever persisted, and he was admitted because of general malaise, appetite loss, and epigastralgia on December 5. In his past medical history, he had papillary carcinoma of the thyroid and underwent thyroidectomy when he was 27 years old, and thereafter he has been taking 1-thyroxin and active vitamin D3. He had syphilis infection in 1995. In recent years, he frequently visited Southeast Asia for sight-seeing. On admission, physical examination revealed a temperature of 38.5°C, blood pressure 106/70 mmHgwith a pulse rate of 90/min, and a respiration rate 14/min. His consciousnesswas alert. He was not icteric or anemic. Bilateral cervical and inguinal lymph nodes were markedly swollen and tender. The throat was hyperemic; however, oral candidiasis or reticular leukoplakia was not observed. He had a tender liver, extending 1.5 cm below the right costal margin. Hepatic Encephalopathy in Primary HIV-1 bance as being hepatic encephalopathy and possible meningitis, although we did not perform electroencephalography (EEG). In addition, blood urea nitrogen (BUN)was 7 mg/dl. Westarted intravenous administration of methylprednisolone (mPSL) (500 mg/day) and glycerol. With the therapy his consciousness disturbance and liver dysfunction including hyperammoninemia were gradually improved. In addition, the Fischer ratio determinedwith blood amino acid distribution, which was measured on December ll, was 2.94 (normally 2.6^.5). Wetapered intravenous mPSLand changed it to oral prednisolone (PSL) and tapered it. He recovered completely about 4 weeks later ( Fig.   1) Whenhis condition was ameliorated, the results of serologic studies were obtained ( Table 2 ). Serologic test ruled out acute infection of EBvirus, cytomegalovirus, herpes simplex types 1 and 2, varicella zoster, human herpes type 6, measles viruses, and hepatitis types A, B and C viruses. In an analysis of lymphocyte subset, the CD4+/CD8+ ratio was as low as 0. ined CSF extensively. CSF cultures were negative for bacteria and fungi. Polymerase chain reaction of CSFfor EB virus, cytomegalovirus, herpes simplex types 1 and 2, and human herpes type 6 viruses were all negative.
Takentogether weconcludedthat a series of his symptoms was caused by primary HIV-1 infection. Furthermore, we diagnosed the disease as acquired immunodeficiency syndrome The pathogenesis of hepatic encephalopathy in our case is unclear. The CD4+/CD8+ratio was 0.2 and CD4+cell count was 164/|il. Cooper et al reported that the range of CD4+/CD8+ ratio after seroconversion was from 0.44 to 1.50 and that CD4+ cell counts after seroconversion were from 400 to 900/|ul (1) . Both values in our patient were very low, suggesting HIV-1-associated excess immunologic reaction. Wemeasured cytokine concentrations using enzyme-linked immunosorbent assay (ELISA) kits in a serum specimen obtained on Decem- HIV-1infection. The excess reaction might have led to the hepatic encephalopathy as in fulminant hepatitis caused by hepatitis type B virus. Improvement of the encephalopathy by bolus mPSLin our patient may support this hypothesis. As another cause of consciousness disturbance, HIVencephalopathy or HIV-1-caused meningitis should be taken into consideration, because plasma HIV-1 RNAlevel was very high (more than 7.5xlO5 copies/ml). However, HIV encephalopathy or meningitis might be unlikely, since brain edema was not noted on CTscan and his consciousness was improved before the start of HAART. The CD4+ count recovered to 575/|il and his plasma HIV-1 RNAamount decreased to 2.3xlO2 copies/ml by HAARTand he remains well 5 monthsafter seroconversion. As a result of this report, weurge clinicians to be aware of hepatic encephalopathy as a clinical manifestation of primary HIV-1 infection. It is important to make a diagnosis of primary HIV-1 infection as early as possible for the purpose of the prevention of further HIV-1 transmission and early therapeutic intervention. In addition, to diagnose primary HIV-1 infection earlier, simultaneous examination of the antibody to HIV-1, Western blot analysis, and plasma HIV-1 RNAmay be useful.
